NIXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug NIXIN contains one active pharmaceutical ingredient (API):

1	Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE
	Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair.
	Read more about Moxifloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9884	Solution/Drops	Nixin Eye Drops SOL_DROPS 0.5%	Ophthalmic Solution	10/11/2020
B4-9885	Tablet	Nixin Tablet TAB 400 mg		30/11/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA14	Moxifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA14
S01AE07		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9884, B4-9885